At a glance
ClinicalIndex Comparison RecordN/ACompleted· 32 enrolled
Drug / intervention
Drospirenone and ethinyl estradiol +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Oral Contraceptive Pill for Premenstrual Worsening of Depression.
In Brief
A clinical study evaluating Drospirenone and ethinyl estradiol and Placebo for Premenstrual Syndrome and Depression. Completed, enrolled 32 participants across 1 site.
Detailed Summary
To determine if augmentation with the oral-contraceptive pill containing drospirenone and ethinyl estradiol is more effective than placebo in the treatment of premenstrual breakthrough of depression.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPremenstrual Syndrome, Depression
CountriesUnited States
CollaboratorsBayer
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2008
First PostedMar 2008
Primary CompletionMay 2011
TodayJul 2026
First PostedMar 12, 2008
Enrollment StartFeb 1, 2008
Primary CompletionMay 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 18.3 years ago
Interventions
Drospirenone and ethinyl estradioldrug
Once daily by mouth
Placebodrug
Once daily by mouth